Prokineticin

Prokineticins are a family of signaling molecules that play a role in various physiological processes. They are also known as endocrine factors (Endo-1 and Endo-2) and were initially identified for their ability to stimulate gastrointestinal motility. The prokineticin family consists of two main ligands, prokineticin-1 (PK1) and prokineticin-2 (PK2), which bind to two specific G protein-coupled receptors, prokineticin receptor-1 (PKR1) and prokineticin receptor-2 (PKR2).

These receptors are expressed in a wide range of tissues, including the nervous system, gastrointestinal tract, immune cells, and reproductive organs. Consequently, prokineticins have been implicated in a diverse array of functions. In the gastrointestinal system, they contribute to smooth muscle contraction and the regulation of gut motility. In the nervous system, prokineticins are involved in neuronal development, survival, and pain perception. They have also been linked to the regulation of the sleep-wake cycle and feeding behavior.

Beyond these roles, prokineticins have been investigated for their involvement in inflammation, angiogenesis (the formation of new blood vessels), and wound healing. Their diverse functions have made them targets of research for potential therapeutic applications in conditions affecting the gastrointestinal system, neurological disorders, and inflammatory diseases. Further research continues to elucidate the full spectrum of prokineticin activity and their therapeutic potential.